Gilad Gershon is CEO of UKI2S portfolio company Tropic Biosciences. Here he joins Oliver Sexton as part of a seminar hosted by UKI2S and BBSRC to discuss his experiences leading a growing innovative agritech company.
CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality
Zentraxa announce seed financing to progress their platform technology for precision biomaterials
MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
From £25,000 to 100M degrees: Tokamak Energy moves closer to commercial fusion
HydRegen receives funding to implement their proprietary enzyme platform into sustainable chemical processes
Mirico monitors impact of cattle grazing and fertiliser strategies on agricultural greenhouse gas emissions
Q5D Technology announces a $2.5m seed investment to take its technology and business to the next stage
Oxford Space Systems in Ground Breaking Programme for Innovative Space Solutions
CellCentric secures investment from the American Cancer Society’s impact venture capital fund
Gilad Gershon is CEO of UKI2S portfolio company Tropic Biosciences. Here he joins Oliver Sexton as part of a seminar hosted by UKI2S and BBSRC to discuss his experiences leading a growing innovative agritech company.